Research ArticleOriginal Article
Open Access

Global patterns, temporal trends and socioeconomic inequalities in the burden of breast cancer: a population-based study across 185 countries

Weijia Kong, Hengna Lin, Jie Li, Yaxiong Nie, Rongshou Zheng and Di Liang
Cancer Biology & Medicine July 2026, 20260059; DOI: https://doi.org/10.20892/j.issn.2095-3941.2026.0059

References

  1. 1.↵
    2. Bray F,
    3. Laversanne M,
    4. Sung H,
    5. Ferlay J,
    6. Siegel RL,
    7. Soerjomataram I, et al.
    Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024; 74: 229–63.
    OpenUrlCrossRefPubMed
  2. 2.↵
    International Agency for Research on Cancer. Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. 2022.
  3. 3.↵
    World Health Organization. Breast Cancer. Geneva, Switzerland: World Health Organization. 2022.
  4. 4.↵
    2. Coles CE,
    3. Earl H,
    4. Anderson BO,
    5. Barrios CH,
    6. Bienz M,
    7. Bliss JM, et al.
    The lancet breast cancer commission. Lancet. 2024; 403: 1895–950.
    OpenUrlCrossRefPubMed
  5. 5.↵
    2. Heer E,
    3. Harper A,
    4. Escandor N,
    5. Sung H,
    6. Mccormack V,
    7. Fidler-Benaoudia MM.
    Global burden and trends in premenopausal and postmenopausal breast cancer: a population-based study. Lancet Glob Health. 2020; 8: e1027–37.
    OpenUrl
  6. 6.↵
    2. Brinton LA,
    3. Gaudet MM,
    4. Gierach GL.
    Cancer Epidemiology and Prevention. 4th Edition. New York: Oxford University Press. 2017: 861–88.
  7. 7.↵
    2. Wang S,
    3. Zheng R,
    4. Li J,
    5. Zeng H,
    6. Li L,
    7. Chen R, et al.
    Global, regional, and national lifetime risks of developing and dying from gastrointestinal cancers in 185 countries: a population-based systematic analysis of GLOBOCAN. Lancet Gastroenterol Hepatol. 2024; 9: 229–37.
    OpenUrlPubMed
  8. 8.↵
    2. Ulrich S,
    3. Hingorani AD,
    4. Martin J,
    5. Vallance P.
    Lifetime risk of developing coronary heart disease. Lancet. 1999; 353: 925.
    OpenUrlPubMedWeb of Science
  9. 9.↵
    2. Zheng R,
    3. Wang S,
    4. Zhang S,
    5. Zeng H,
    6. Chen R,
    7. Sun K, et al.
    Global, regional, and national lifetime probabilities of developing cancer in 2020. Sci Bull (Beijing). 2023; 68: 2620–8.
    OpenUrlPubMed
  10. 10.↵
    2. Sasieni PD,
    3. Shelton J,
    4. Ormiston-Smith N,
    5. Thomson CS,
    6. Silcocks PB.
    What is the lifetime risk of developing cancer? The effect of adjusting for multiple primaries. Br J Cancer. 2011; 105: 460–5.
    OpenUrlCrossRefPubMedWeb of Science
  11. 11.↵
    2. Li M,
    3. Wen X,
    4. Liang X,
    5. Liu M,
    6. Zhang L,
    7. Zheng R.
    Global, regional, and national lifetime risk of developing and dying from lung cancer in 2022: a population-based study in 185 countries. Chin Med J (Engl). 2024; 137: 3101–7.
    OpenUrlPubMed
  12. 12.↵
    United Nations. World Population Prospects 2019. New York, NY, USA: United Nations. 2019.
  13. 13.↵
    United Nations Development Programme. Human Development Index (HDI). New York, USA: United Nations Development Programme. 2020.
  14. 14.↵
    World Health Organization. Who Global Health Expenditure Database. Geneva, Switzerland: World Health Organization. 2024.
  15. 15.↵
    World Bank Group. Databank. Washington, USA: World Bank Group. 2025.
  16. 16.↵
    International Agency for Research on Cancer. Cancer Incidence in Five Continents Plus (CI5plus): IARC CancerBase. Lyon, France: International Agency for Research on Cancer. 2024.
  17. 17.↵
    World Health Organization. WHO Mortality Database. Geneva, Switzerland: World Health Organization. 2022.
  18. 18.↵
    2. Ahmad AS,
    3. Ormiston-Smith N,
    4. Sasieni PD.
    Trends in the lifetime risk of developing cancer in Great Britain: comparison of risk for those born from 1930 to 1960. Br J Cancer. 2015; 112: 943–7.
    OpenUrlCrossRefPubMed
  19. 19.↵
    2. Discacciati A,
    3. Palazzolo MG,
    4. Park JG,
    5. Melloni GEM,
    6. Murphy SA,
    7. Bellavia A.
    Estimating and presenting non-linear associations with restricted cubic splines. Int J Epidemiol. 2025; 54: dyaf088.
  20. 20.↵
    2. Lei S,
    3. Zheng R,
    4. Zhang S,
    5. Wei W.
    The burden and long-term trends of breast cancer by different menopausal status in China. J Natl Cancer Cent. 2024; 4: 326–34.
    OpenUrlPubMed
  21. 21.↵
    World Health Organization. Research on the Menopause in the 1990s: Report of a WHO Scientific Group. Geneva: World Health Organization. 1996.
  22. 22.↵
    2. Arnold M,
    3. Morgan E,
    4. Rumgay H,
    5. Mafra A,
    6. Singh D,
    7. Laversanne M, et al.
    Current and future burden of breast cancer: global statistics for 2020 and 2040. Breast. 2022; 66: 15–23.
    OpenUrlCrossRefPubMed
  23. 23.↵
    2. Chen Z,
    3. Xu L,
    4. Shi W,
    5. Zeng F,
    6. Zhuo R,
    7. Hao X, et al.
    Trends of female and male breast cancer incidence at the global, regional, and national levels, 1990–2017. Breast Cancer Res Treat. 2020; 180: 481–90.
    OpenUrlCrossRefPubMed
  24. 24.↵
    2. Clinton SK,
    3. Giovannucci EL,
    4. Hursting SD.
    The world cancer research fund/american institute for cancer research third expert report on diet, nutrition, physical activity, and cancer: impact and future directions. J Nutr. 2020; 150: 663–71.
    OpenUrlCrossRefPubMed
  25. 25.↵
    2. Colditz GA,
    3. Bohlke K.
    Priorities for the primary prevention of breast cancer. CA Cancer J Clin. 2014; 64: 186–94.
    OpenUrlCrossRefPubMed
  26. 26.↵
    2. Xu Y,
    3. Gong M,
    4. Wang Y,
    5. Yang Y,
    6. Liu S,
    7. Zeng Q.
    Global trends and forecasts of breast cancer incidence and deaths. Sci Data. 2023; 10: 334.
    OpenUrlPubMed
  27. 27.↵
    2. Lund E,
    3. Busund LR,
    4. Holden L.
    Curvilinear incidence models for parity in the entire fertility range for cancers of the breast, ovary, and endometrium: a follow-up of the Norwegian 1960 Census. Int J Cancer. 2025; 156: 2118–26.
    OpenUrlPubMed
  28. 28.↵
    2. Sherr HR,
    3. Soliman AS,
    4. Bertrand KA,
    5. Hirko KA.
    Persistent poverty and late-stage breast cancer diagnosis in the USA: impacts of rural residence, race, and time within Surveillance, Epidemiology, and End Results registries, 2004 to 2021. Cancer Causes Control. 2025; 36: 1589–97.
    OpenUrlPubMed
  29. 29.↵
    2. Allemani C,
    3. Matsuda T,
    4. Di Carlo V,
    5. Harewood R,
    6. Matz M,
    7. Nikšić M, et al.
    Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018; 391: 1023–75.
    OpenUrlCrossRefPubMed
  30. 30.↵
    2. Verhoeven D,
    3. Allemani C,
    4. Kaufman C,
    5. Mansel R,
    6. Siesling S,
    7. Anderson B.
    Breast Cancer: global quality care optimizing care delivery with existing financial and personnel resources. Esmo Open. 2020; 4: e000861.
  31. 31.↵
    2. Joko-Fru WY,
    3. Miranda-Filho A,
    4. Soerjomataram I,
    5. Egue M,
    6. Akele-Akpo MT,
    7. N’Da G, et al.
    Breast cancer survival in sub-Saharan Africa by age, stage at diagnosis and human development index: a population-based registry study. Int J Cancer. 2020; 146: 1208–18.
    OpenUrlCrossRefPubMed
  32. 32.↵
    2. Duggan C,
    3. Trapani D,
    4. Ilbawi AM,
    5. Fidarova E,
    6. Laversanne M,
    7. Curigliano G, et al.
    National health system characteristics, breast cancer stage at diagnosis, and breast cancer mortality: a population-based analysis. Lancet Oncol. 2021; 22: 1632–42.
    OpenUrlCrossRefPubMed
  33. 33.↵
    2. Kantelhardt EJ,
    3. Cubasch H,
    4. Hanson C.
    Taking on breast cancer in East Africa: global challenges in breast cancer. Curr Opin Obstet Gynecol. 2015; 27: 108–14.
    OpenUrlPubMed
  34. 34.↵
    2. Yip CH,
    3. Anderson BO.
    The Breast Health Global Initiative: clinical practice guidelines for management of breast cancer in low- and middle-income countries. Expert Rev Anticancer Ther. 2014; 7: 1095–104.
    OpenUrl
  35. 35.↵
    2. Atun R,
    3. Cavalli F.
    The global fight against cancer: challenges and opportunities. Lancet. 2018; 391: 412–3.
    OpenUrlPubMed
  36. 36.
    Independent UK Panel on Breast Cancer Screening. The benefits and harms of breast cancer screening: an independent review. Lancet. 2012; 380: 1778–86.
    OpenUrlCrossRefPubMedWeb of Science
  37. 37.
    2. McCormack V,
    3. McKenzie F,
    4. Foerster M,
    5. Zietsman A,
    6. Galukande M,
    7. Adisa C, et al.
    Breast cancer survival and survival gap apportionment in sub-Saharan Africa (ABC-DO): a prospective cohort study. Lancet Glob Health. 2020; 8: e1203–12.
    OpenUrlPubMed
  38. 38.↵
    2. Song QK,
    3. Wang XL,
    4. Zhou XN,
    5. Yang HB,
    6. Li YC,
    7. Wu JP, et al.
    Breast cancer challenges and screening in china: lessons from current registry data and population screening studies. Oncologist. 2015; 20: 773–9.
    OpenUrlAbstract/FREE Full Text
  39. 39.↵
    2. Olopade OI,
    3. Fackenthal JD,
    4. Dunston G,
    5. Tainsky MA,
    6. Collins F,
    7. Whitfield-Broome C.
    Breast cancer genetics in African Americans. Cancer. 2003; 97: 236–45.
    OpenUrlCrossRefPubMed
  40. 40.↵
    2. Schouten LJ,
    3. Straatman H,
    4. Kiemeney LA,
    5. Verbeek AL.
    Cancer incidence: life table risk versus cumulative risk. J Epidemiol Community Health. 1994; 48: 596–600.
    OpenUrlAbstract/FREE Full Text
  41. 41.↵
    2. Liao L.
    Inequality in breast cancer: global statistics from 2022 to 2050. Breast. 2025; 79: 103851.
  42. 42.↵
    2. Filho AM,
    3. Laversanne M,
    4. Ferlay J,
    5. Colombet M,
    6. Piñeros M,
    7. Znaor A, et al.
    The GLOBOCAN 2022 cancer estimates: data sources, methods, and a snapshot of the cancer burden worldwide. Int J Cancer. 2025; 156: 1336–46.
    OpenUrlCrossRefPubMed
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools

Jump to section

Keywords